Order Article Reprints

Saito S, Kawashima Y, Tanaka H, Yoshimura N, Tsukita Y, Saito R, Nakagawa T, Inomata M, Nagashima H, Sugawara S. Prospective Multi-Institutional Observational Study of Retreatment with Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1/PD-L1 Plus Chemotherapy: NJLCG (North Japan Lung Cancer Group) Trial 1901. Cancers. 2025; 17(9):1551. https://doi.org/10.3390/cancers17091551

Saito, Shin, Yosuke Kawashima, Hisashi Tanaka, Naruo Yoshimura, Yoko Tsukita, Ryota Saito, Taku Nakagawa, Minehiko Inomata, Hiromi Nagashima, and Shunichi Sugawara. 2025. "Prospective Multi-Institutional Observational Study of Retreatment with Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1/PD-L1 Plus Chemotherapy: NJLCG (North Japan Lung Cancer Group) Trial 1901" Cancers 17, no. 9: 1551. https://doi.org/10.3390/cancers17091551

Saito, S., Kawashima, Y., Tanaka, H., Yoshimura, N., Tsukita, Y., Saito, R., Nakagawa, T., Inomata, M., Nagashima, H., & Sugawara, S. (2025). Prospective Multi-Institutional Observational Study of Retreatment with Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1/PD-L1 Plus Chemotherapy: NJLCG (North Japan Lung Cancer Group) Trial 1901. Cancers, 17(9), 1551. https://doi.org/10.3390/cancers17091551